In this edition of our “What They’re Watching” series, Sherell McDearmon, Director of Strategic Alliances at Bristol Meyers Squibb, lauds Arizona’s passage earlier this year of House Bill 2144. The legislation requires health plans to cover biomarker testing, which McDearmon says was a key goal for her organization’s broader mission of improving accessibility and health equity.
She also discusses Bristol Meyers Squibb’s commitment of $150 million to promoting health equity over several years.
“We have been actively engaged in how we are operationalizing that internally and externally. How does our organization have a health equity lens on everything we do, from sales to marketing to R&D to policy?”